Nov 18, 2014 at 19:39 | Source: CNBC-TV18
USFDA had revoked tentative approvals granted to Ranbaxy for generic versions of two drugs - AstraZeneca's heartburn drug Nexium & Roche's antiviral drug Valcyte.
Nov 18, 2014 at 14:55 | Source: Reuters
In the suit filed in the District Court for the District of Columbia, Ranbaxy said the FDA's move violated constitutional rights, exceeded the agency's statutory authority, and was "arbitrary, capricious, and otherwise contrary to law."
Nov 14, 2014 at 19:17 | Source: CNBC-TV18
Drug makers Sun Pharma and Merck may be heading to terminate their branded generics joint venture for emerging markets, reports Archana Shukla quoting sources.
Nov 14, 2014 at 15:52 | Source: Moneycontrol.com
Aarti Drugs Ltd has informed BSE that the Board of Directors of the Company at is meeting held on November 14, 2014, has declared Interim dividend at Rs 5 (50 percent) per share for the financial year 2014- 2015.
Nov 14, 2014 at 11:59 | Source: CNBC-TV18
The pharma major is hopeful of maintaining its revenue growth guidance of 13-15 percent for FY15 though the margins may get impacted marginally.
Nov 13, 2014 at 23:45 | Source: CNBC-TV18
Disappointing set of numbers from Cipla in the September quarter. Cipla reported a poor operating performance on back of muted sales growth and a sharp decline in exports.
Nov 13, 2014 at 21:21 | Source: PTI
Drug major Cipla today posted a consolidated net profit of Rs 298.68 crore for the quarter ended September 30, 2014, on account of robust sales in domestic market.
Nov 13, 2014 at 17:13 | Source: Moneycontrol.com
Ishita Drugs and Industries has reported a sales total income from operations of Rs 2.29 crore and a net profit of Rs 0.05 crore for the quarter ended Sep '14
Nov 13, 2014 at 17:07 | Source: CNBC-TV18
Sun Pharma reported a mixed set of numbers for the second quarter ended September 30. Consolidated Net Profit rose by 15 percent to Rs 1,572 crore, but was a miss as per street estimates. The drug major posted a net profit of Rs 1,362 crore during the same period of previous fiscal.
Nov 13, 2014 at 17:03 | Source: Moneycontrol.com
Godavari Drugs has reported a sales total income from operations of Rs 14.95 crore and a net profit of Rs 1.39 crore for the quarter ended Sep '14